Zobrazeno 1 - 10
of 850
pro vyhledávání: '"Kebriaeezadeh A"'
Autor:
Shiri M, Navaei-Nigjeh M, Baeeri M, Rahimifard M, Mahboudi H, Shahverdi AR, Kebriaeezadeh A, Abdollahi M
Publikováno v:
International Journal of Nanomedicine, Vol Volume 11, Pp 6239-6250 (2016)
Mahdi Shiri,1,2,* Mona Navaei-Nigjeh,1,3,* Maryam Baeeri,1 Mahban Rahimifard,1 Hossein Mahboudi,4 Ahmad Reza Shahverdi,5 Abbas Kebriaeezadeh,1 Mohammad Abdollahi1,6,7 1Department of Toxicology and Pharmacology, Faculty of Pharmacy and Pharmaceutical
Externí odkaz:
https://doaj.org/article/4086fe75fa19404b9321e782094a4014
Autor:
Niusha Esmaealzadeh, Abass Kebriaeezadeh, Pardis Zaboli, Motahareh Kheradmand, Pedram Ebrahimnejad
Publikováno v:
Journal of Mazandaran University of Medical Sciences, Vol 33, Iss 223, Pp 139-145 (2023)
Background and purpose: Understanding consumer behavior has a crucial role in marketing process. Successful pharmaceutical marketing affects consumer behavior. In this study we aimed to identify the effect of social media purchasing behavior of patie
Externí odkaz:
https://doaj.org/article/d5e6f5faa4f344cc9240cc9b3c7d780b
Autor:
Hadi Abbasian, Reza Yousefi-Zenouz, Abdollah Amirkhani, Masoud Shirzadeh, Akbar Abdollahiasl, Shekoufeh Nikfar, Mohammadreza Siahi-Shadabad, Abbas Kebriaeezadeh
Publikováno v:
Complexity, Vol 2024 (2024)
Analyzing the supply chain (SC) of biopharmaceutical drugs can be challenging due to their complexity, the existence of a wide variety of risks, and the dynamics of the system. This paper presents a framework for evaluating the SC risks of Iranian bi
Externí odkaz:
https://doaj.org/article/8ef54d10003741519b10ad59fbbf1789
Autor:
Abolfazl Sadeghi, Yahya Bayazidi, Majid Davari, Abbas Kebriaeezadeh, Amin Assarian, Alireza Esteghamati, Sepideh Yousefi
Publikováno v:
Iranian Journal of Medical Sciences, Vol 48, Iss 3, Pp 286-291 (2023)
Background: Clinical guidelines and expert committees have recently suggested that the hemoglobin A1C (HbA1c) should be individualized based on various criteria. Data regarding the achievement of individualized glycemic targets in type 2 diabetes mel
Externí odkaz:
https://doaj.org/article/5a4849b5f5204306a75bbedd543afc4e
Publikováno v:
BMC International Health and Human Rights, Vol 5, Iss 1, p 5 (2005)
Abstract Background Pharmaceuticals have made an important contribution to global reductions in morbidity and mortality. To help save lives and improve health, it is important to be sure about equity to access to drugs, drug efficacy, quality and saf
Externí odkaz:
https://doaj.org/article/e3417bbe79934effbd44f296af628168
Autor:
Ghasemzadeh, Peivand, Rezayat Sorkhabadi, Seyed Mahdi, Kebriaeezadeh, Abbas, Nazari, Jamal Aldin, Farzaneh, Mandana, Mehralian, Gholamhossein
Publikováno v:
Journal of Knowledge Management, 2021, Vol. 26, Issue 10, pp. 2579-2601.
Externí odkaz:
http://www.emeraldinsight.com/doi/10.1108/JKM-01-2021-0069
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Majid Davari, Yahya Bayazidi, Abbas Kebriaeezadeh, Alireza Esteghamati, Fatemeh Bandarian, Zahra Kashi, Adele Bahar, Sepideh Yousefi
Publikováno v:
BMC Endocrine Disorders, Vol 22, Iss 1, Pp 1-9 (2022)
Abstract Background Appropriate service delivery, access to high quality of cares and optimal management of type 2 diabetes mellitus (T2DM) can decrease the risk of micro and macro vascular complications and mortality. Therefore, monitoring the quali
Externí odkaz:
https://doaj.org/article/23c8e6a2f0494a2b9dbc95b5c516518f
Publikováno v:
Journal of Pharmacoeconomics and Pharmaceutical Management, Vol 8, Iss 4 (2023)
Background: Coronavirus (COVID-19) pandemic has caused great shocks across all sectors of society. The pandemic highlighted three crucial policy issues (i.e., healthcare spending, social determinants of health, and health equity). It is also projecte
Externí odkaz:
https://doaj.org/article/c2f266f71ff74a3bb62e7bac33fb042b
Publikováno v:
Journal of Pharmacoeconomics and Pharmaceutical Management, Vol 8, Iss 3 (2023)
Background: Initial combination therapy, preferentially fixed-dose combination (FDC) therapy is recommended by most of the clinical guidelines for the management of hypertension in adults. However, there is inadequate evidence on the impact of FDC on
Externí odkaz:
https://doaj.org/article/eeebe865027a4672ad1eca188add1985